Singapore markets open in 4 hours 55 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,308.15 +61.47 (+1.17%) Dow
39,908.00 +349.89 (+0.88%) Nasdaq
16,742.39 +231.21 (+1.40%) Bitcoin USD
65,886.99 +4,313.02 (+7.00%) CMC Crypto 200
1,392.96 +125.01 (+9.86%)
GILD Jul 2024 65.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:09PM EDT. Market open.
| Previous close | 3.7000 |
| Open | 3.9000 |
| Bid | 3.4000 |
| Ask | 3.5500 |
| Strike | 65.00 |
| Expiry date | 2024-07-19 |
| Day's range | 3.6000 - 4.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.1k |
Business WireKite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.